Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 144Neoplasms 130Prostatic Neoplasms 81Carcinoma, Non-Small-Cell Lung 79Lung Neoplasms 65Colorectal Neoplasms 46Carcinoma, Hepatocellular 37Stomach Neoplasms 33Multiple Myeloma 28Brain Neoplasms 28Uterine Cervical Neoplasms 27Melanoma 26Pancreatic Neoplasms 25Rectal Neoplasms 24Ovarian Neoplasms 24Head and Neck Neoplasms 23Colonic Neoplasms 23Urinary Bladder Neoplasms 22Hematologic Neoplasms 22Neoplasm Metastasis 21Esophageal Neoplasms 20Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Endometrial Neoplasms 17Recurrence 15Cardiovascular Diseases 15Thyroid Neoplasms 14Lymphoma 14Liver Neoplasms 14

Interventions

Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Pediatric Solid Tumor × Clear all
NCT02520713 2026-04-28

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

Dana-Farber Cancer Institute

Active not recruiting
825 enrolled
Other solid neoplasm

Pediatric Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡